D
2.76
0.13 (4.94%)
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Decoy Therapeutics Inc. | Bercampur | - |
AISkor Stockmoo
-0.4
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | 3.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -2.5 |
| Purata | -0.38 |
|
Decoy Therapeutics Inc is a preclinical-stage biotechnology company developing peptide conjugate drug candidates using machine learning, artificial intelligence tools, and high-throughput synthesis techniques. The company's initial pipeline is focused on respiratory viruses and GI cancers. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BURLESON TESS | 3.05 | - | 2,000 | 6,100 |
| GAUTHIER PATRICIA G. | 3.05 | - | 2,000 | 6,100 |
| HANISH ARNOLD C | 3.05 | - | 3,000 | 9,150 |
| HIBNER BARBARA LOUISE | 3.05 | - | 4,216 | 12,859 |
| LAMMERS PAUL | 3.05 | - | 2,000 | 6,100 |
| LIEBER JONATHAN I | 3.05 | - | 2,000 | 6,100 |
| MARSCHEL PETER KLAUS | 3.05 | - | 3,900 | 11,895 |
| MCVICAR WILLIAM K. | 3.05 | - | 3,000 | 9,150 |
| PIERCE FREDERICK II | 3.05 | - | 33,455 | 102,038 |
| ROSENBLUM MARK J | 3.05 | - | 9,682 | 29,530 |
| Jumlah Keseluruhan Kuantiti Bersih | 65,253 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 199,022 | |||
| Purata Pembelian Keseluruhan ($) | 3.05 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| GAUTHIER PATRICIA G. | Pengarah | 31 Aug 2026 | Diperolehi (+) | 2,000 | 3.05 | 6,100 |
| MCVICAR WILLIAM K. | Pengarah | 31 Aug 2026 | Diperolehi (+) | 3,000 | 3.05 | 9,150 |
| BURLESON TESS | Pengarah | 31 Aug 2026 | Diperolehi (+) | 2,000 | 3.05 | 6,100 |
| LAMMERS PAUL | Pengarah | 31 Aug 2026 | Diperolehi (+) | 2,000 | 3.05 | 6,100 |
| HANISH ARNOLD C | Pengarah | 31 Aug 2026 | Diperolehi (+) | 3,000 | 3.05 | 9,150 |
| HIBNER BARBARA LOUISE | Pegawai | 31 Aug 2026 | Diperolehi (+) | 4,216 | 3.05 | 12,859 |
| ROSENBLUM MARK J | Pegawai | 31 Aug 2026 | Diperolehi (+) | 9,682 | 3.05 | 29,530 |
| MARSCHEL PETER KLAUS | Pegawai | 31 Aug 2026 | Diperolehi (+) | 3,900 | 3.05 | 11,895 |
| PIERCE FREDERICK II | Pegawai | 31 Aug 2026 | Diperolehi (+) | 33,455 | 3.05 | 102,038 |
| LIEBER JONATHAN I | Pengarah | 31 Aug 2026 | Diperolehi (+) | 2,000 | 3.05 | 6,100 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |